Scribd Logo
Upload

Welcome to Scribd!

  • 17K views

    MV + FeSO4 Drug Study

    Uploaded by

    milkv
    B.V. is a 20-year-old female, 5'2" and 60kg, diagnosed with G1P1 PU 31 wks. She is prescribed Mulvitron, containing multivitamins and iron, to prevent postpartum anemia and maintain nutritional balance. The medication contains water-soluble vitamins and iron supplements, and works by allowing iron to enter the bloodstream and be incorporated into iron stores. Nurses should monitor the patient's blood work and medication adherence, and inform her that dark stools are common but not harmful.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    MV + FeSO4 Drug Study

    Uploaded by

    milkv
    17K views2 pages
    B.V. is a 20-year-old female, 5'2" and 60kg, diagnosed with G1P1 PU 31 wks. She is prescribed Mulvitron, containing multivitamins and iron, to prevent postpartum anemia and maintain nutritional balance. The medication contains water-soluble vitamins and iron supplements, and works by allowing iron to enter the bloodstream and be incorporated into iron stores. Nurses should monitor the patient's blood work and medication adherence, and inform her that dark stools are common but not harmful.

    Original Description:

    a drug study about Multivitamins + Ferrous Sulfate

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    B.V. is a 20-year-old female, 5'2" and 60kg, diagnosed with G1P1 PU 31 wks. She is prescribed Mulvitron, containing multivitamins and iron, to prevent postpartum anemia and maintain nutritional balance. The medication contains water-soluble vitamins and iron supplements, and works by allowing iron to enter the bloodstream and be incorporated into iron stores. Nurses should monitor the patient's blood work and medication adherence, and inform her that dark stools are common but not harmful.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    17K views2 pages

    MV + FeSO4 Drug Study

    Uploaded by

    milkv
    B.V. is a 20-year-old female, 5'2" and 60kg, diagnosed with G1P1 PU 31 wks. She is prescribed Mulvitron, containing multivitamins and iron, to prevent postpartum anemia and maintain nutritional balance. The medication contains water-soluble vitamins and iron supplements, and works by allowing iron to enter the bloodstream and be incorporated into iron stores. Nurses should monitor the patient's blood work and medication adherence, and inform her that dark stools are common but not harmful.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    You are on page 1of 2

    Name of Patient

    B. V.

    Age

    20 y.o

    Height

    52

    Diagnosis

    G1P1 PU 31 wks. AOG/LMP cephalic, IPTL, severe


    preeclampsia with pulmonary congestion
    M. M. Olmillo

    Sex

    Female

    Weight

    60 kg

    Website

    milkv.co.vu

    A/N

    Youre welcome

    Author

    DRUG DATA
    Generic name:
    Multivitamins +
    FeSO4

    CLASSIFICATION
    Pharmacologic:
    Water-soluble
    vitamins, iron
    supplements

    Trade name/s:
    Mulvitron
    Patients dose:
    1 tab OD
    Minumum dose:
    125 mg

    Therapeutic:
    Vitamins & minerals,
    antianemics

    MECHANISM OF
    ACTION

    An essential mineral
    found in haemoglobin,
    myoglobin, and many
    enzymes. Enters the
    bloodstream and is
    transported to the
    organs of the
    reticuloendothelial
    system (liver, spleen,
    bone marrow), where it
    is separated out and
    becomes part of iron
    stores.

    Maximum dose:
    750 mg
    Pregnancy Category
    Risk: A
    Availability:
    Tablets 150,
    200, 500mg;
    capsules 300,
    500mg; syrups
    250mg/5mL
    Route:
    PO

    INDICATION

    General
    indications:
    Prevention and
    treatment of ironvitamin and
    dietary deficiency
    anemias; used in
    anemia due to
    blood loss during
    menstruation,
    infections,
    surgery, delivery,
    intoxications,
    parasitosis, or
    other causes &
    anemias during
    pregnancy

    Onset: 4 days
    Peak: 7-10 days
    Duration: 2-4 months
    Metabolism: mostly
    recycled, small daily
    losses
    Distribution: crosses
    placenta, enters breast
    milk
    Excretion: sweat,
    urine, bile

    Patients actual
    indication:
    MV + FeSO4 is
    prescribed for
    postpartum
    patients to
    prevent the
    occurrence of
    pregnancyinduced anemia
    and keep her
    nutritionally
    balanced.

    CONTRAINDICATI
    ON

    Hemochromatosis,
    hemosiderosis, or other
    evidence of iron
    overload; anemias not
    due to iron deficiency
    Precautions:
    Use cautiously in peptic
    ulcer, ulcerative colitis or
    regional enteritis,
    alcoholism, severe
    hepatic impairment,
    severe renal impairment,
    rheumatoid arthritis,
    pregnancy or lactation
    Interaction:
    Drug-drug: antacids that
    contain calcium.
    tatracylcines,
    biphosphates, H2
    antagonists, protonpump inhibitors
    Drug-food: iron
    absorption is decreased
    33-50% by concurrent
    administration of food

    ADVERSE
    EFFECTS

    CNS: seizures,
    dizziness,
    headaches,
    syncope
    CV: hypotension,
    hypertension,
    tachycardia
    GI: nausea,
    constipation, dark
    stools, diarrhea,
    vomiting
    Dermatologic:
    flushing, urticaria
    Respiratory:
    cough, dyspnea
    MS: arthralgia,
    myalgia
    Local: pain at IM
    site
    Others: staining of
    teeth, anaphylaxis,
    sweating

    NURSING
    RESPONSIBILITIE
    S

    Before:
    > monitor blood studies of patient
    > observe proper dosage of
    medication
    > note other drugs patient is taking to
    avoid possible interactions
    > verify the patients identity
    During:
    > most effectively absorbed if
    administered 1 or 2 hrs before meal
    > take with a full glass of water/juice
    > do not crush/chew enteric-coated
    tablets and do not open capsules
    > encourage patient to avoid using
    antacids, coffee, tea, dairy products
    within 1 hour after
    > inform patient about dark, green or
    black stools to avoid panic
    After:
    > monitor pts blood studies
    > inform patient about what possible
    adverse effects that may occur
    > assess bowel function for
    constipation/diarrhea
    > document and record.

    Source: 2011
    Lippincotts NDG

    Source: 2011
    Lippincotts NDG

    Source: 2011
    Lippincotts NDG

    Source: 2011
    Lippincotts NDG

    Source: 2011
    Lippincotts NDG

    Source: 2011
    Lippincotts NDG

    Source:
    2011 Lippincotts Nursing Drug Guide

    You might also like